Patient Perceptions of Osteoporosis Management: a Qualitative Pilot Study by a Patient Advisory Group

Overview

Journal Arch Osteoporos

Publisher Springer

Date 2025 Jan 15

PMID 39812712

Authors

R M Javier

F Debiais

F Alliot-Launois

D Poivret

P Bosgiraud

F Barbe

M Bouyssie

M Devert

F Roux

M P Sacchi

S Sirot

P Halbout

T Chevalley

J Y Reginster

B Cortet

Affiliations

Soon will be listed here.

Abstract

Purpose: The management of osteoporosis (OP) even after a fracture has declined over recent years despite the actions of the medical societies concerned with this disease. The objective of this pilot study was to investigate patients' perceptions of OP, their treatment pathways, and how information is obtained.

Methods: The Association Française de Lutte Anti-Rhumatismale (AFLAR) constituted an advisory group of 7 French patients (mean age 63.7 years [54-74 years]), with various stages of OP and duration of disease. A qualitative, anonymized study was conducted with an open-ended semi-structured questionnaire, with a contribution of the International Osteoporosis Foundation (IOF) and the "Groupe de Recherche et Informations sur les Ostéoporoses" (GRIO).

Results: The onset of OP was often sudden, with the fracture occurring in a context of deep misunderstanding of OP by both the public and physicians. The patients have confidence in the physician, mostly a rheumatologist, who informs about OP and initiates the treatment. The main cause of non-adherence being major fears and uncertainties about efficacy and safety of treatments. Medical information is considered as insufficient, or poorly understood. Negative information has the highest impact, even if the sources seem unreliable, such as media. There is no trust in pharmaceutical companies and the ethics of physicians are in question.

Conclusion: This IOF/GRIO/AFLAR Patient Advisory Group pilot study illustrates the numerous barriers to effective OP management. Complete and sustained medical information, especially at the time of diagnosis and initiation of treatment, seems essential to counteract the contradictory information, which are exclusively negative.

References

Chevalley T, Hoffmeyer P, Bonjour J, Rizzoli R . An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int. 2002; 13(6):450-5. DOI: 10.1007/s001980200053. View

Curtis E, Dennison E, Cooper C, Harvey N . Osteoporosis in 2022: Care gaps to screening and personalised medicine. Best Pract Res Clin Rheumatol. 2022; 36(3):101754. PMC: 7614114. DOI: 10.1016/j.berh.2022.101754. View

Roux C, Thomas T, Paccou J, Bizouard G, Crochard A, Toth E . Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study. JBMR Plus. 2021; 5(7):e10507. PMC: 8260818. DOI: 10.1002/jbm4.10507. View

Sale J, Bogoch E, Hawker G, Gignac M, Beaton D, Jaglal S . Patient perceptions of provider barriers to post-fracture secondary prevention. Osteoporos Int. 2014; 25(11):2581-9. DOI: 10.1007/s00198-014-2804-4. View

Merle B, Dupraz C, Haesebaert J, Barraud L, Aussedat M, Motteau C . Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study. Osteoporos Int. 2018; 30(1):177-185. DOI: 10.1007/s00198-018-4720-5. View

Arnold M, Rutherford M, Bardot A, Ferlay J, Andersson T, Myklebust T . Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019; 20(11):1493-1505. PMC: 6838671. DOI: 10.1016/S1470-2045(19)30456-5. View

Raybould G, Babatunde O, Evans A, Jordan J, Paskins Z . Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review. Arch Osteoporos. 2018; 13(1):55. PMC: 5938310. DOI: 10.1007/s11657-018-0470-4. View

Beaton D, Dyer S, Jiang D, Sujic R, Slater M, Sale J . Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy's fracture clinic screening program. Osteoporos Int. 2013; 25(1):289-96. DOI: 10.1007/s00198-013-2430-6. View

Kanis J, Norton N, Harvey N, Jacobson T, Johansson H, Lorentzon M . SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021; 16(1):82. PMC: 8172408. DOI: 10.1007/s11657-020-00871-9. View

10.

Cortet B, Chauvin P, Feron J, Grange L, Coulomb A, Launois R . Fragility fractures in France: epidemiology, characteristics and quality of life (the EPIFRACT study). Arch Osteoporos. 2020; 15(1):46. DOI: 10.1007/s11657-019-0674-2. View

11.

Skedros J, Holyoak J, Pitts T . Knowledge and opinions of orthopaedic surgeons concerning medical evaluation and treatment of patients with osteoporotic fracture. J Bone Joint Surg Am. 2006; 88(1):18-24. DOI: 10.2106/JBJS.D.02949. View

12.

Cortet B, Benichou O . Adherence, persistence, concordance: do we provide optimal management to our patients with osteoporosis?. Joint Bone Spine. 2006; 73(5):e1-7. DOI: 10.1016/j.jbspin.2006.02.006. View

13.

Freedman K, Kaplan F, Bilker W, Strom B, Lowe R . Treatment of osteoporosis: are physicians missing an opportunity?. J Bone Joint Surg Am. 2000; 82(8):1063-70. DOI: 10.2106/00004623-200008000-00001. View

14.

Bullock L, Crawford-Manning F, Cottrell E, Fleming J, Leyland S, Edwards J . Developing a model Fracture Liaison Service consultation with patients, carers and clinicians: a Delphi survey to inform content of the iFraP complex consultation intervention. Arch Osteoporos. 2021; 16(1):58. PMC: 7989712. DOI: 10.1007/s11657-021-00913-w. View

15.

Briot K, Grange L, Cortet B, Feron J, Chauvin P, Coulomb A . Real-world care for individuals aged over fifty with fractures in France: Evidence for a wide care gap-The EPIFRACT Study. Joint Bone Spine. 2020; 87(5):467-473. DOI: 10.1016/j.jbspin.2020.04.007. View

16.

Giangregorio L, Dolovich L, Cranney A, Adili A, DeBeer J, Papaioannou A . Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns. 2008; 74(2):213-20. PMC: 5101077. DOI: 10.1016/j.pec.2008.08.001. View

17.

Akesson K, Marsh D, Mitchell P, McLellan A, Stenmark J, Pierroz D . Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013; 24(8):2135-52. PMC: 3706734. DOI: 10.1007/s00198-013-2348-z. View

18.

Yood R, Mazor K, Andrade S, Emani S, Chan W, Kahler K . Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med. 2008; 23(11):1815-21. PMC: 2585659. DOI: 10.1007/s11606-008-0772-0. View

19.

Eliasaf A, Amitai A, Maram Edry M, Yosselson Superstine S, Pikielny P . Compliance, Persistence, and Preferences Regarding Osteoporosis Treatment During Active Therapy or Drug Holiday. J Clin Pharmacol. 2016; 56(11):1416-1422. DOI: 10.1002/jcph.738. View

20.

Javaid M, Kyer C, Mitchell P, Chana J, Moss C, Edwards M . Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool. Osteoporos Int. 2015; 26(11):2573-8. DOI: 10.1007/s00198-015-3192-0. View